| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Richard Roedel last filed a Form 4 in December 2024, as Director at LXU. The filings on record cover 3 companies. Richard Roedel's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 124,346 shares of LXU. Net of sales, the LXU filings show accumulation of 26,820 shares.
Richard Roedel has 70 Form 4 filings on record from May 2015 to December 2024, across 3 companies: Director at BrightView (BV), 2019–2024; Director at Clarivate (CLVT), 2020–2024; Director at Lsb Industries (LXU), 2015–2024.
The 109 reported transactions were 57 stock awards, 22 tax withholdings, 15 gifts and 6 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $904K and no sales.
The largest open-market purchase was 19,193 shares of CLVT at an average $26.07 on June 11, 2021, about $500K. Twelve months later CLVT was down 47%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.